Sensex

up-green-arrow

Nifty

up-green-arrow

USDINR

down-red-arrow

GBPINR

down-red-arrow

EURINR

down-red-arrow

Board of Directors
Rubicon Research Ltd
Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value()
544578
INE506V01022
82.1385423
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
RUBICON
112.76
21214.9
EPS(TTM)
Face Value()
Div & Yield %
11.42
1
0.12
 

Chairman & Independent DirectoCHANGAVALLI VENKAT
Executive Director & MDPRATIBHA SUDHIR PILGAONKAR
Executive Director & CEOPARAG SUGANCHAND SANCHETI
Non Executive DirectorVarun Talukdar
Shantanu Rastogi
Anand Agarwal
Independent Non Exe. DirectorK G Ananthakrishnan
MILIND ANIL PATIL
Company Sec. & Compli. OfficerDEEPASHREE OMKAR TANKSALE

Attention Investor :

"Prevent unauthorised transactions in your account ; Update your mobile numbers/email IDs with Us. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day” - Issued in the interest of Investors"

"KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."

"No need to issue cheques by investors while subscribing to Equity IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

"Contents which are exclusively for Non-Broking Products/Services, "Mutual Fund, Mutual Fund-SIP, Research reports, Insurance, etc. where the Member is just a distributor. These are not Exchange traded product and the Member is just acting as distributor. It should also state that all disputes with respect to the distribution activity, would not have access to Exchange investor redressal forum or Arbitration mechanism."

A Muthoot M George Enterprise